/
/
Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
This content is Free Access.
Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
27,803 Views
•
08:35 min
•
January 04, 2012
DOI:
Özet
Automatically generated
Type B gelatin-based engineered nanovectors system (GENS) was developed for systemic gene delivery and transfection in the treatment of pancreatic cancer. By modification with epidermal growth factor receptor (EGFR) specific peptide on the surface of nanparticles, they could target on EGFR receptor and release plasmid under reducing environment, such as high intracellular glutathione concentrations.
Explore More Videos
Therapeutic Gene DeliveryTransfectionPancreatic Cancer CellsEpidermal Growth Factor Receptor-targeted Gelatin NanoparticlesPancreatic CancerGene TherapyDelivery SystemSustained Transgene ExpressionGelatinDNA EncapsulationPlasmid Supercoiled StructureTransfection EfficiencyThiolation Of GelatinSulfhydryl GroupsDisulfide BondGlutathionePoly(ethylene Glycol)PEG-modified GENSSystemic CirculationTumor MassNeovasculature
Read Article
Cite this Article
Xu, J., Amiji, M. Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles. J. Vis. Exp. (59), e3612, doi:10.3791/3612 (2012).
Copy